| Prognosis of lasso-like penalized Cox models with tumor profiling improves prediction over clinical data alone and benefits from bi-dimensional pre-screening R Jardillier, D Koca, F Chatelain, L Guyon BMC cancer 22 (1), 1045, 2022 | 6 | 2022 |
| COL7A1 expression improves prognosis prediction for patients with clear cell renal cell carcinoma atop of stage D Koca, I Séraudie, R Jardillier, C Cochet, O Filhol, L Guyon Cancers 15 (10), 2701, 2023 | 5 | 2023 |
| Optimal microRNA sequencing depth to predict cancer patient survival with random forest and Cox models R Jardillier, D Koca, F Chatelain, L Guyon Genes 13 (12), 2275, 2022 | 4 | 2022 |
| Impact of heterozygous ALK1 mutations on the transcriptomic response to BMP9 and BMP10 in endothelial cells from hereditary hemorrhagic telangiectasia and pulmonary arterial … T Al Tabosh, H Liu, D Koça, M Al Tarrass, L Tu, S Giraud, L Delagrange, ... Angiogenesis, 1-17, 2024 | 2 | 2024 |
| BMP9 is a key player in endothelial identity and its loss is sufficient to induce arteriovenous malformations A Desroches-Castan, D Koca, H Liu, C Roelants, L Resmini, N Ricard, ... Cardiovascular research, cvae052, 2024 | | 2024 |
| Large-scale phosphoproteomics reveals activation of the MAPK/GADD45β/P38 axis and cell cycle inhibition in response to BMP9 and BMP10 stimulation in endothelial cells M Al Tarrass, L Belmudes, D Koça, V Azemard, H Liu, T Al Tabosh, ... Cell Communication and Signaling 22 (1), 158, 2024 | | 2024 |
| ALK1 heterozygosity is not sufficient for driving hht pathogenesis T Al Tabosh, H Liu, D Koca, S Dupuis-Girod, L Tu, S Giraud, M Beaudoin, ... ANGIOGENESIS 26 (1), S8-S9, 2023 | | 2023 |
